Diabetes, Vol 42, Issue 2 345-350, Copyright © 1993 by American Diabetes Association

ARTICLES

Immunochemical detection of advanced glycation end products in lens crystallins from streptozocin-induced diabetic rat

H Nakayama, T Mitsuhashi, S Kuwajima, S Aoki, Y Kuroda, T Itoh and S Nakagawa
Second Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

To reassess the significance of AGEs in cataract formation in diabetic animals, we measured amounts of AGEs in lens crystallins from STZ-induced diabetic animals with a newly developed ELISA. Lenses were removed at 5 and 20 wk after STZ injection. In 20-wk diabetic rats, all lenses were cataractous but not in control rats. In 20-wk diabetic compared with control rats, significant increases were observed in AGEs (172.3 +/- 18.3 vs. 14.3 +/- 1.7 AU, P < 0.01) and fluorescence (2.04 +/- 0.22 vs. 1.27 +/- 0.10 AU, P < 0.05). The amounts of AGEs in lens crystallins, measured by the ELISA, were > 12-fold higher in diabetic rats. In agreement with earlier studies, we found that fluorescence in lens crystallins increased by 61% in diabetic rats. In 5-wk diabetic rats, all lenses were noncataractous. In 5-wk diabetic compared with control rats, significant increases were observed in AGEs (84.1 +/- 7.7 vs. 9.4 +/- 1.5 AU, P < 0.01) and fluorescence (1.45 +/- 0.06 vs. 1.05 +/- 0.06 AU, P < 0.01). Analysis of the AGE content by ELISA showed that accumulation of AGEs in diabetic lens crystallins does markedly occur with time, and a large amount of AGEs exists in the diabetic (cataractous) lens crystallins. The disproportionate elevation of AGEs, measured by the ELISA, compared with fluorescence suggests that the actual levels of AGEs in cataractous lens crystallins from diabetic animals are higher than previously anticipated, and nonfluorescent AGEs may exist in diabetic lens crystallins.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Baidoshvili, P.A.J. Krijnen, K. Kupreishvili, C. Ciurana, W. Bleeker, R. Nijmeijer, C.A. Visser, F.C. Visser, C.J.L.M. Meijer, W. Stooker, et al. N{epsilon}-(Carboxymethyl)lysine Depositions in Intramyocardial Blood Vessels in Human and Rat Acute Myocardial Infarction: A Predictor or Reflection of Infarction? Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2497 - 2503. [Abstract] [Full Text] [PDF]

				N. Yamabe, T. Yokozawa, T. Oya, and M. Kim Therapeutic Potential of (-)-Epigallocatechin 3-O-Gallate on Renal Damage in Diabetic Nephropathy Model Rats J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 228 - 236. [Abstract] [Full Text] [PDF]

				N. Nakano, K. Fukuhara-Takaki, T. Jono, K. Nakajou, N. Eto, S. Horiuchi, M. Takeya, and R. Nagai Association of Advanced Glycation End Products with A549 Cells, a Human Pulmonary Epithelial Cell Line, Is Mediated by a Receptor Distinct from the Scavenger Receptor Family and RAGE. J. Biochem., May 1, 2006; 139(5): 821 - 829. [Abstract] [Full Text] [PDF]

				S. Amano, Y. Kaji, T. Oshika, T. Oka, R. Machinami, R. Nagai, and S. Horiuchi Advanced glycation end products in human optic nerve head Br. J. Ophthalmol., January 1, 2001; 85(1): 52 - 55. [Abstract] [Full Text]

				D. A Schaumberg, R. J Glynn, W. G Christen, S. E Hankinson, and C. H Hennekens Relations of body fat distribution and height with cataract in men Am. J. Clinical Nutrition, December 1, 2000; 72(6): 1495 - 1502. [Abstract] [Full Text] [PDF]

				M. B. Davidson, D. L. Schriger, A. L. Peters, and B. Lorber Relationship Between Fasting Plasma Glucose and Glycosylated Hemoglobin: Potential for False-Positive Diagnoses of Type 2 Diabetes Using New Diagnostic Criteria JAMA, April 7, 1999; 281(13): 1203 - 1210. [Abstract] [Full Text] [PDF]

				H. Shoda, S. Miyata, B.-F. Liu, H. Yamada, T. Ohara, K. Suzuki, M. Oimomi, and M. Kasuga Inhibitory Effects of Tenilsetam on the Maillard Reaction Endocrinology, May 1, 1997; 138(5): 1886 - 1892. [Abstract] [Full Text] [PDF]

				S. Miyata, B.-F. Liu, H. Shoda, T. Ohara, H. Yamada, K. Suzuki, and M. Kasuga Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes J. Biol. Chem., February 14, 1997; 272(7): 4037 - 4042. [Abstract] [Full Text] [PDF]

				E. B. Casey, H.-R. Zhao, and E. C. Abraham Role of Glycine 1 and Lysine 2 in the Glycation of Bovine [IMAGE]B-Crystallin J. Biol. Chem., September 1, 1995; 270(35): 20781 - 20786. [Abstract] [Full Text] [PDF]

				N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products J. Biol. Chem., January 26, 2001; 276(5): 3195 - 3202. [Abstract] [Full Text] [PDF]

				N. Ohgami, R. Nagai, A. Miyazaki, M. Ikemoto, H. Arai, S. Horiuchi, and H. Nakayama Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products J. Biol. Chem., April 13, 2001; 276(16): 13348 - 13355. [Abstract] [Full Text] [PDF]